Eric Johnston, Cantor Fitzgerald chief equity and macro strategist, joins 'Money Movers' to discuss Johnston's thesis for ...

We recently compiled a list of the 14 AI Stocks Making Waves on Wall Street. In this article, we are going to take a look at ...

Cantor Fitzgerald assumed coverage of Zevra Therapeutics (ZVRA) with an Overweight rating and $25 price target Zevra is a rare disease, ...

In a report released yesterday, Ross Osborn from Cantor Fitzgerald reiterated a Buy rating on Avita Medical (RCEL – Research Report), with a ...

Fintel reports that on January 6, 2025, Cantor Fitzgerald initiated coverage of aTyr Pharma (NasdaqCM:ATYR) with a Overweight ...

Cantor Equity Partners I, Inc. (Nasdaq: CEPO) (the "Company") announced today that it priced its initial public offering of 20,000,000 Class A ordinary shares at $10.00 per share. The shares are ...

On Tuesday, Vincerx Pharma Inc (VINC) stock saw a modest uptick, ending the day at $0.21 which represents no change from the prior close of of $0.21. The stock opened at $0.21 and touched a low of ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

Cantor Fitzgerald reiterated their overweight rating on shares of TeraWulf (NASDAQ:WULF – Free Report) in a research report released on Monday,Benzinga reports. Cantor Fitzgerald currently has a ...

KeyCorp upgraded shares of Acadia Healthcare (NASDAQ:ACHC – Free Report) from a sector weight rating to an overweight rating ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 1.56% of ...

Cantor Fitzgerald Equity Opportunity Fd earns a Low Process Pillar rating. The primary detractor from the rating is the fund's unimpressive long-term risk-adjusted performance. This can be seen in ...